Literature DB >> 27393571

Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis.

Yusuke Yamamoto1, Mehmet Akif Türkoğlu2, Takeshi Aramaki3, Teiichi Sugiura2, Yukiyasu Okamura2, Takaaki Ito2, Ryo Ashida2, Sunao Uemura2, Takashi Miyata2, Yoshiyasu Kato2, Yuko Kakuta4, Yasuni Nakanuma4, Katsuhiko Uesaka2.   

Abstract

BACKGROUND: The indications for lymph node dissection (LND) for intrahepatic cholangiocarcinoma (ICC) are controversial.
METHODS: Seventy patients with mass-forming dominant ICC underwent hepatectomy with systematic LND or lymph node sampling between 2003 and 2013. We defined the computed tomography (CT) ratio as the CT value (Hounsfield units) of the tumor divided by the CT value (Hounsfield units) of the liver parenchyma in the late arterial phase, and investigated the indications for LND with hepatectomy for ICC.
RESULTS: A multivariate analysis identified lymph node metastasis (LNM; n = 19, p = 0.012) and perineural invasion (p = 0.017) as independent predictors of survival. The median survival time and 5-year survival rate in patients exhibiting LNM were 31.1 months and 16.0 %, respectively. In a subgroup analysis of patients without LNM, overall survival was comparable between patients treated with LND and those treated without LND (p = 0.801). A multivariate analysis of the preoperatively measurable parameters revealed that a CT ratio <0.88 and macroscopic periductal infiltration were independently associated with LNM. We developed a score predicting LNM of mass-forming dominant ICC (LMIC score), assigning 1 point for each of these risk factors. The percentages of patients with LNM with an LMIC score of 0, 1, or 2 points were 0, 35, and 58 %, respectively.
CONCLUSIONS: The vascularity of ICC is associated with important prognostic factors, LNM, and perineural invasion. LN dissection would be conducted in patients with an LMIC score of one or two points but can be omitted in patients with an LMIC score of zero.

Entities:  

Year:  2016        PMID: 27393571     DOI: 10.1245/s10434-016-5382-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Bile duct angulation and tumor vascularity are useful radiographic features for differentiating pancreatic head cancer and intrapancreatic bile duct cancer.

Authors:  Atsushi Kohga; Yusuke Yamamoto; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Takeshi Aramaki; Keiko Sasaki; Katsuhiko Uesaka
Journal:  Surg Today       Date:  2018-02-19       Impact factor: 2.549

2.  Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas?

Authors:  Fangqiang Wei; Chen Lu; Liuxin Cai; Hong Yu; Xiao Liang; Xiujun Cai
Journal:  Surg Endosc       Date:  2016-12-28       Impact factor: 4.584

3.  The Evaluation of the Eighth Edition of the AJCC/UICC Staging System for Intrahepatic Cholangiocarcinoma: a Proposal of a Modified New Staging System.

Authors:  Yusuke Yamamoto; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Katsuhisa Ohgi; Yasuni Nakanuma; Katsuhiko Uesaka
Journal:  J Gastrointest Surg       Date:  2019-04-22       Impact factor: 3.452

4.  A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.

Authors:  Gu-Wei Ji; Fei-Peng Zhu; Yu-Dong Zhang; Xi-Sheng Liu; Fei-Yun Wu; Ke Wang; Yong-Xiang Xia; Yao-Dong Zhang; Wang-Jie Jiang; Xiang-Cheng Li; Xue-Hao Wang
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

5.  Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma.

Authors:  Elena Panettieri; Harufumi Maki; Bradford J Kim; HyunSeon Christine Kang; Veronica Cox; Eduardo A Vega; Takashi Mizuno; Shubham Pant; Milind Javle; Jean-Nicolas Vauthey; Yoshikuni Kawaguchi
Journal:  Surg Oncol       Date:  2021-12-31       Impact factor: 3.279

6.  Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.

Authors:  Yusuke Yamamoto; Teiichi Sugiura; Akiko Todaka; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Yuko Kakuda; Yasuni Nakanuma; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

Review 7.  Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings.

Authors:  Mohammed Saleh; Mayur Virarkar; Vlad Bura; Raul Valenzuela; Sanaz Javadi; Janio Szklaruk; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11

8.  Predicting peritumoral Glisson's sheath invasion of intrahepatic cholangiocarcinoma with preoperative CT imaging.

Authors:  Yingfan Mao; Yong Zhu; Yudong Qiu; Weiwei Kong; Liang Mao; Qun Zhou; Jun Chen; Jian He
Journal:  Quant Imaging Med Surg       Date:  2019-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.